Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
19 hedge funds and large institutions have $3.82M invested in Guardion Health Sciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
27% more funds holding
Funds holding: 15 → 19 (+4)
20% less capital invested
Capital invested by funds: $4.8M → $3.82M (-$983K)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$316K |
| 2 |
Millennium Management
New York
|
+$111K |
| 3 |
Two Sigma Advisers
New York
|
+$32.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$64.2K |
| 2 |
VF
Virtu Financial
New York
|
-$55K |
| 3 |
BlackRock
New York
|
-$13.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$2.26K |
GHSI Hedge Fund Activity: Q3 2021 in Review
19 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q3 2021, worth a combined $3.82M — down 20% from $4.8M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GHSI positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $316K. The largest seller was Morgan Stanley, cutting an estimated $64.2K.
- 19 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q3 2021, up from 15 in Q2 2021.
- Funds reported $3.82M of Guardion Health Sciences, Inc. Common Stock stock for Q3 2021, down 20% quarter-over-quarter.
- 5 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q3 2021 and 1 closed out, a net change of +4 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q3 2021 was Renaissance Technologies, an estimated $316K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q3 2021 was Morgan Stanley, an estimated $64.2K sold.
Based on aggregated 13F filings for Q3 2021.